Clinical Patient Journey C-Lys

17/10/2024

Do you wish to stay informed about new clinical studies or patient surveys? Use the registration form on our website to sign-up for our newsletter.

Click this link to subscribe: https://www.c-lys.com/en/registration-form

29/02/2024

Rare Disease Day, 29th February 2024: united for hope in clinical research.

Rare Diseases, though uncommon, impact millions of lives globally. Breakthroughs in research and clinical development, is advancing the field, albeit slowly. Let´s champion and advocate together for more support in the field to combat these diseases and create a more supportive world for those who suffer from them.

For more information please visit: https://www.rarediseaseday.org/

07/02/2024

Last Sunday was the World Cancer Day - to recognize the power of working together and to honor and remember, as everyone can be affected by cancer. In addition the month of February is the cancer awareness month. During this period, everyone may pay extra attention to the impact of cancer.

Press 👍 if you feel well informed about cancer and / or its treatment, press 🥰 if you are actively supporting the "working together" , comment with ❤️ to give some extra love to everyone who is fighting against cancer.

28/11/2023

Of particular concern is the increase in gastric cancer cases in younger age groups (

20/10/2023

Breast cancer is the most common cancer in women, with more than 2.3 millions diagnosed every year, globally.

Two of the latest research advances in breast cancer are the benefit of CDK4/6 inhibitors in early stages and the use of antibody-drug conjugates (ADCs) in metastatic disease.

22/09/2023

World Day of Chronic Myeloid Leukemia (CML)

Let’s celebrate together the Chronic Myeloid Leukemia Day..!!
CML is caused by the translocation between chromosomes 9 and 22 and has an incidence of 1-2 cases/100.000 adults. One of the main fields of current research is the study of TKIs in 3rd Line in its chronic phase (Jabbour et al. Am J Hematol 2023).

11/06/2023

Prostate cancer is the most common tumor in men. Since its symptoms do not usually appear until it is large enough to start obstructing the ureter, screening has become a key basic healthcare activity in developed countries, and this has allowed for earlier diagnosis and 10-year survival >90%.

30/05/2023

20/05/2023

Today we celebrate the International Day for Clinical Trials. Attracting clinical trials fosters a country´s position at the forefront of R&D to contribute to new strategies and therapies in the unmet medical needs' area. Many European countries have been, for years, the best destinations to invest in this field across all therapeutic areas.

29/03/2023

cérébrales cerveau France

L’étude NANORAD2 continue, n’hésitez pas à contacter les différents centres investigateurs.

Si vous étiez pré-sélectionnés sur base du questionnaire, n’oubliez pas de contacter le centre de votre choix.